Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mallinckrodt Plc (NYSE:MNK)

32.16
Delayed Data
As of Oct 18
 -0.20 / -0.62%
Today’s Change
31.51
Today|||52-Week Range
68.12
-35.45%
Year-to-Date

Today’s Trading

Previous close32.36
Today’s open32.46
Day’s range31.78 - 32.46
Volume1,801,297
Average volume (3 months)2,392,210
Market cap$3.1B
Dividend yield--
Data as of 4:01pm ET, 10/18/2017

Growth & Valuation

Earnings growth (last year)+78.72%
Earnings growth (this year)--
Earnings growth (next 5 years)+6.50%
Revenue growth (last year)+1.01%
P/E ratio17.6
Price/Sales2.30
Price/Book0.66

Competitors

 Today’s
change
Today’s
% change
AGNPRAAllergan plc-35.25-4.95%
AKRXAkorn Inc-0.07-0.21%
PBYIPuma Biotechnology I...-0.75-0.60%
OPKOPKO Health Inc-0.10-1.47%
Data as of 3:59pm ET, 10/18/2017

Financials

Next reporting dateOctober 31, 2017
EPS forecast (this quarter)$1.82
Annual revenue (last year)$3.4B
Annual profit (last year)$548.0M
Net profit margin14.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark C. Trudeau
Senior Vice President-
Global Operations
Frank Scholz
Corporate headquarters
Chesterfield, Derbyshire

Forecasts